 | |||||||
| news | |||||||
| NEWS | |||||||
MSK Researchers Present Advances in Lung Cancer Treatment at 2025 ASCO Meeting A targeted immunotherapy drug developed to treat small cell lung cancer (SCLC) appears to work better than standard chemotherapy in patients whose disease has recurred after initial chemotherapy. Findings from the international phase 3 clinical trial of ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment